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2ABSTRACT
There is a clinical need for objective evidence-based measures that are sensitive and specific
to ADHD when compared with other neurodevelopmental disorders. This study evaluated the
incremental validity of adding an objective measure of activity and computerised cognitive
assessment to clinical rating scales to differentiate adult ADHD from Autism spectrum
disorders (ASD).
Adults with ADHD (n=33) or ASD (n=25) performed the QbTest, comprising a Continuous
Performance Test with motion-tracker to record physical activity. QbTest parameters
measuring inattention, impulsivity and hyperactivity were combined to provide a summary
score (‘QbTotal’). Binary stepwise logistic regression measured the probability of assignment
to the ADHD or ASD group based on scores on the Conners Adult ADHD Rating Scale–
subscale E (CAARS-E) and Autism Quotient (AQ10) in the first step and then QbTotal added
in the second step. The model fit was significant at step 1 (CAARS-E, AQ10) with good
group classification accuracy. These predictors were retained and QbTotal was added,
resulting in a significant improvement in model fit and group classification accuracy. All
predictors were significant. ROC curves indicated superior specificity of QbTotal. The
findings present preliminary evidence that adding QbTest to clinical rating scales may
improve the differentiation of ADHD and ASD in adults.
Keywords: Continuous Performance Test; assessment; QbTest
31. Introduction
Attention Deficit/Hyperactivity Disorder (ADHD) is characterised by core symptoms of
inattention, hyperactivity and impulsivity and is increasingly recognised as a condition that
affects adults as well as children (Farone et al., 2006; Fayyad et al., 2007). The clinician’s
judgment is the most widely accepted method of ADHD assessment in children, integrating
parent, teacher and patient reports with direct clinical observation. Applying this approach to
adults has proved more difficult, however as there may be fewer informants (parents,
teachers) available and recent evidence suggests clinical rating scales for adults such as the
Conners’ Adult ADHD Rating Scale (CAARS) are not as well validated as their child
counterparts (van Voorhees et al., 2011). In addition, such rating scales may be relatively
insensitive to key clinical features such as physical over-activity (Lis et al., 2010) and rely on
self-evaluation skills and retrospective recall that may be unreliable. These difficulties mean
that the clinician may have less information available when trying to reach a diagnosis and
are further exacerbated when ADHD presents with overlapping symptoms of other
psychiatric diagnoses (Davidson, 2007; Van Voorhees et al., 2011).
Autism is a pervasive developmental disorder encompassing social and communication
difficulties and stereotyped repetitive behaviours (American Psychiatric Association, 2013)
prevalent in about 1% of the adult population (Brugha et al., 2011). ADHD and Autism
Spectrum Disorders (ASD) often co-occur (Rommelse et al., 2011) and exhibit overlapping
difficulties in social interaction and communication (Geurts et al., 2004a), inattention and
hyperactivity (Frazier et al., 2001), language delay (Hagberg et al., 2010) and executive
function deficits (Geurts et al., 2004b). These phenotypic similarities may lead both to
potential ‘double-counting’ of symptoms with the result of falsely inflated diagnostic co-
morbidity between the two conditions and patients misclassified into the incorrect diagnostic
4category. As such, there is a need for more objective and reliable methods to accurately
differentiate ADHD and ASD.
Cognitive tests allow specific aspects of cognition to be measured and isolated from
one another (such as sustained attention versus inhibitory control) and may provide access to
cognitive features which show ‘double dissociation’ and allow better distinction between
conditions than self-report measures. They may also provide additional information to help
differentiate between neurodevelopmental disorders by measuring cognitive features that are
specific to one condition. The tool that has perhaps most frequently been used with this aim
in ADHD is the continuous performance test (CPT), a measure of sustained attention and
inhibitory control in which participants monitor a continuous stream of stimuli to report the
presentation of a target stimulus. There has been some success using the CPT to differentiate
ADHD from typically developing children (Epstein et al., 2003) and adults (Schoechlin and
Engel, 2005) but the results are less compelling when differentiating ADHD from other
psychiatric groups (Riccio and Reynolds, 2001; Solanto et al., 2004), perhaps because
impairments in attention and executive functions are shared by a number of neuropsychiatric
disorders. The studies conducted to date primarily addressed the question of whether the CPT
could be used in isolation to differentiate ADHD from healthy individuals or those with other
disorders. A more pragmatic and clinically relevant question is whether such tests can be
used alongside other clinical information to improve assessment of ADHD (Roth and Saykin,
2004). Furthermore, the CPT measures attention and inhibitory control but has the limitation
of not assessing motor activity, a cardinal feature of ADHD.
The Quantified behaviour Test (QbTest; Qbtech Ltd, www.qbtech.com) is a cognitive
assessment tool developed specifically to measure the core symptoms of ADHD in
conjunction with clinical interview measures and rating scales; not as a stand-alone
diagnostic tool. The test combines a computerised CPT designed to measure inattention and
5impulsivity with a motion-tracking infra-red camera to measure activity (hyperactivity)
during test completion. Sensitivity of the measures to ADHD has been reported in affected
individuals (Edebol et al., 2013) and at-risk siblings (Reh et al., 2014) and there is also
evidence of sensitivity to medication response in adults (Bijlenga et al., 2015). However no
research has investigated the specificity of the test in adult ADHD when compared with adult
ASD. It is important to investigate the potential clinical utility and incremental validity of
QbTest because, despite a weak evidence base, it has already been introduced into clinical
practice in a number of healthcare clinics in the United Kingdom (U.K.) and Europe. Further
research is therefore urgently needed to evaluate the utility of QbTest as an aid to diagnostic
decision-making in the assessment of ADHD.
The aim of the present study was to determine whether QbTest aids the differentiation of
adult ADHD from ASD when combined with brief, standardised clinical rating scales, as part
of a full clinical assessment. We predicted that adding QbTest to brief clinical rating scales
for ADHD (CAARS) and autism (AQ10) would show incremental validity with significantly
improved distinction between ADHD and ASD, and compared with using clinical rating
scales alone.
2. Methods
2.1 Participants
Thirty-seven adults aged 18 to 60 years with a DSM-IV diagnosis of ADHD (24
males; mean age 30.46 ± SD 10) years and 25 adults aged 19 to 47 years with a ICD10
diagnosis of Asperger’s Syndrome (19 males, mean age 33.22 ± SD 11.74 years) were
recruited to the study. Participation in the study was voluntary and signed consent was
obtained for all participants. Ethical approval for the study was granted by the local Research
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Healthcare NHS Trust. The groups were matched on age, gender ratio, and socio-economic
status (see Table 1). Socio-economic status was estimated for each participant using the Index
of Multiple Deprivation (Department for Communities and Local Government 2015) which
categorises English postal districts according to several indices of deprivation. The categories
are decile ranks where low ranks (1-3) represent high levels of deprivation and high ranks (8-
10) represent low levels of deprivation.
The ADHD sample was recruited from a specialist adult ADHD clinic in Nottingham,
U.K. All were interviewed by a psychiatrist with expertise in adult ADHD using the
Diagnostic Interview for ADHD in Adults (Kooij and Francken, 2010) to establish current
and lifetime DSM-5 ADHD diagnosis, in addition to self- and observer-reported symptom
ratings using the Conners Adult ADHD Rating Scale (CAARS) (Conners et al., 1999),
Autism Quotient (Baron-Cohen et al., 2001) (further information on these measures are given
below) and Adult ADHD Rating Scale (Kessler et al., 2005). Fifty participants were
approached to take part and gave consent. Of these, 3 were excluded as an ADHD diagnosis
was not established, 3 were excluded due to non-completion of the test and 2 were excluded
as they did not stop their ADHD medication prior to the test as requested. A further 5
participants with a dual diagnosis of ADHD and ASD were excluded, and AQ10 scores were
unavailable for 4, leaving a final sample of 33. Of the final sample, 25 were diagnosed
ADHD-Combined, 3 ADHD-Predominantly Inattentive and 1 ADHD-Predominantly
Hyperactive/Impulsive; sub-type information was unavailable for 3 participants.
The ASD sample was recruited from a specialist service for adults with Asperger
syndrome in Nottingham, U.K. All were assessed by an experienced multidisciplinary team
using the Autism Diagnostic Interview-Revised (ADI-R) (Lord et al., 1994) and the Autism
Diagnostic Observation Schedule (ADOS) (Gotham et al., 2007) to establish ICD10
7diagnosis of Asperger’s Syndrome. Of 34 service-users who consented to participate, 1 failed
to complete the QbTest and 8 were excluded due to comorbid ADHD, leaving a final sample
of 25 participants.
All diagnoses used ICD-10 criteria other than for ADHD where DSM-5 criteria were
used, as is accepted practice in the UK. Comorbid diagnoses in the ADHD group included
ICD-10 diagnoses of depression (2), anxiety disorder (2) and emotionally unstable
personality disorder (equivalent to DSM-5 borderline personality disorder) (2). Within the
ASD group, ICD-10 comorbid diagnoses included anxiety (4), depression (2), anxiety and
depression (1), bipolar disorder (1) and substance misuse (1). Any participants taking
prescribed psychostimulant medication were asked to abstain for 24 hours before assessment
as these medications would ameliorate performance deficits on QbTest.
2.2 Measures
2.2.1 Self-report clinical measures
The CAARS (Conners et al., 1999) is an 18-item questionnaire with a 5-point rating
scale to measure ADHD symptoms over the preceding 6 months. It comprises 5 sub-scales:
A-Inattention/Memory; B-Hyperactivity/Restlessness, C-Impulsivity/Emotional Lability, D-
Self-Concept, E-ADHD Index. The scale is used extensively in clinical practice and research
and has good test-re-test reliability and high sensitivity and specificity (Erhardt et al., 1999).
The Autism Quotient-10 (AQ-10; Allison et al., 2012; Baron-Cohen et al., 2001) is a
ten-item self-report questionnaire with the purpose of screening for possible autism spectrum
disorders. Responses are made on a scale and a total score is yielded. A score of 6 or above is
potentially indicative of ASD. The scale has high sensitivity and specificity (Allison et al.,
2012).
82.2.2. QbTest
The QbTest is a computerised CPT coupled with an infra-red motion tracking system.
There are two versions of the test: QbTest (6-12) and QbTest (12+) with the latter designed
specifically to avoid potential ceiling effects in adolescents and adults (ages 12+). The CPT
for ages 12+ was used in the present study. The test comprises 600 stimuli presented
sequentially and centrally on a computer screen in pseudorandom order for 200ms each with
an inter stimulus interval (ISI) of 2000ms. Stimuli are blue or red squares and circles.
Participants are required to press a hand-held responder button when an on-screen stimulus
matches in colour (blue or red) and shape (square or circle) with the previous stimulus
(targets) and to withhold the response when the stimuli do not match. Of the total presented
stimuli 150 (25%) are targets. Speed and accuracy are equally encouraged. The task lasts
approximately 20 minutes and is preceded by a 5-minute practice session which includes
standardised on-screen instructions. Measurement of hit rate (proportion of correctly
responded to targets), Reaction Time (RT) to targets and RT variability (standard deviation of
RT) give an index of attention while the proportion of commission errors (incorrect responses
to non-targets) gives an index of impulsivity. The motion-tracking system is an infra-red
camera placed 1 metre from the participant which captures movement by tracking a reflective
headband worn by the participant. Activity is recorded throughout the CPT by recording the
location of the marker on the headband on x-y co-ordinates, at a frequency of 50 samples per
second and with a spatial resolution of 1/27mm per infrared camera unit. Summary scores
(‘q-scores’) in each of these domains (labelled Q-Activity, Q-Inattention, Q-Impulsivity) are
obtained for each individual by transforming the raw data into units of standard deviation
from the mean of an age- and gender- stratified normative sample, after correcting for skew.
Q-scores are therefore equivalent to z-scores (Ulberstad, 2012) and higher Q-scores indicate
greater risk of ADHD. To provide an index equivalent to the CAARS-E ADHD Index and to
9reduce the number of variables entered into regression analysis (see 2.4) a composite QbTest
measure (QbTotal) was computed by calculating the mean of the 3 ‘cardinal’ Q-score
parameters.
2.3. Procedure
The QbTest took place in each clinic and was conducted by a fully trained research
assistant (ZY). All participants watched a short instruction video. The researcher checked
their understanding of the test verbally and by monitoring performance during the
standardised practice test. All participants completed the CAARS, AQ10 and QbTest
immediately before their clinic appointment.
2.4. Data Analysis
To provide an overview of group differences on the QbTest, CAARS and ASD, the
ADHD and ASD groups were compared on each of the QbTest cardinal parameters (Q-
Activity, Q-Inattention, Q-Impulsivity), QbTotal, the 5 CAARS sub-scales (A to E) and the
AQ10 using univariate ANOVA. To reduce type 1 error rate a Bonferroni corrected p-value
of .005 (alpha .05/10) was applied.
To determine whether QbTest improves the differentiation of ADHD from ASD when
added to CAARS and AQ10, binary logistic regression was performed to measure the
probability of assignment to the ADHD or ASD group (dependent variable), based on scores
on the CAARS-E, AQ10 and QbTest (predictor variables). To ensure a good case variable
ratio given the total sample size, the CAARS-E subscale (‘ADHD Index’) was used rather
than all subscales and the QbTest composite score, QbTotal, was used as an equivalent to
CAARS-E. Composite measures also offer greater practical value in a clinical setting by
providing a simple summary score. These variables were entered into logistic regression in
two steps with CAARS-E and AQ10 entered simultaneously in the first step and QbTotal
entered into the second step. This order was chosen as the most sensible to address the
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question of whether QbTest improves the sensitivity and specificity afforded by brief clinical
rating scales. At each step, the goodness of fit of the model was evaluated with chi-square
with a significance threshold of .05. In addition, the percentage of participants correctly
assigned to the ADHD group and to the ASD group was evaluated to determine the
sensitivity and specificity of the model. Tolerance statistics indicated no multi-collinearity
between the variables included in the model. After examining leverage values one participant
in the ADHD group was excluded from the analysis. To determine whether the model was
robust to the order in which the individual predictors were entered, the order of entry of the
predictors was reversed and resulted in the same final classification.
Receiver Operating Characteristic (ROC) curves were calculated for each predictor
variable related to ADHD diagnosis (CAARS-E, QbTotal) to determine which offered the
best sensitivity and specificity to ADHD and to identify associated cut-off scores on each
measure.
3. Results
As shown in Table 1, the ADHD and ASD groups were well-matched on age and gender
distribution. Q-scores (reflecting deviation from a normative sample in standardised units)
were significantly greater in the ADHD than ASD group on all QbTest cardinal parameters
but Q-Impulsivity did not meet the Bonferroni-corrected threshold. The groups also differed
significantly on all sub-scales of the CAARS except CAARS-D (Self-Concept), although the
difference on CAARS-A Inattention/Memory did not survive correction. The ASD group
scored significantly higher on the AQ10.
[Insert Table 1 here]
To determine whether adding QbTotal enhanced the sensitivity and specificity of
identifying ADHD when combined with the CAARS-E ADHD Index and AQ10 alone, these
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variables were entered, stepwise, into binary logistic regression with Group (ADHD, ASD) as
the dependent variable. The goodness of fit of the model at the first step with CAARS-E and
AQ10 entered as predictors was highly significant (χ2 = 31.59, p < .001) yielding group
classification accuracy of 81% (84% sensitivity, 76% specificity, see Table 2) and explaining
57% of variance in the data (Nagelkerke R2 =.57). CAARS-E (Wald = 11.21, p <.01; Exp (β) 
= 1.19, 95% CI = 1.07, 1.32) and AQ10 were both significant predictors (Wald = 9.78, p
<.01; Exp (β) = .46, 95% CI = .28, 75).
In step 2 QbTotal was added to the model and led to a highly significant improvement
in model fit (Step χ2 = 14.11, p <.001, Model χ2 = 45.69, p <.001) with 74% of variance in the
data explained (Nagelkerke R2 = .74) and overall classification accuracy of 90% (94%
sensitivity, 84% specificity). CAARS-E (Wald = 6.21, p<.05, Exp (β) = 1.18, 95% CI = 1.04,
1.33) and AQ10 (Wald = 9.26, p <.01, Exp (β) = .42, 95% CI = .24, .74) remained significant 
and QbTotal was also significant (Wald = 8.95, p<.01, Exp (β) = 6.50, 95% CI = 1.91,
22.17). Detailed figures on the assignment of participants to either the ADHD or ASD
groups at each step of the analysis are shown in Table 2.
[Insert Table 2 here]
ROC curves were computed for CAARS-E and QbTotal and the Area Under the Curve
(AUC) was calculated. As shown in Figure 1, QbTotal yielded the highest AUC value, .87
(classified as ‘good’) while the value for CAARS-E was .77 (‘fair’). The ROCs indicate that
at equivalent sensitivity of around .8, QbTotal demonstrates superior specificity compared
with CAARS-E. On the CAARS-E, sensitivity of .84 and specificity of .60 corresponds to a
T-score of 69. On QbTotal, sensitivity of .84 and specificity of .80 corresponds to a Q-score
of 1.12.
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[Insert Figure 1 here]
4. Discussion
The aim of this study was to determine whether QbTest improved the classification of
adults with ADHD or ASD when added to brief standardised rating scales that are frequently
used in clinical practice. The results confirm our predicted effects; QbTest significantly
improved classification accuracy when combined with two rating scales designed to assess
ADHD (CAARS-E) and ASD (AQ10) compared with using the rating scales alone. This
suggests it may provide a useful, additional source of information when used as part of a full
clinical assessment for ADHD in adults.
One previous study reported good sensitivity and specificity differentiating adult
ADHD from healthy controls using QbTest (Edebol et al., 2013). Uniquely, we demonstrate
that QbTest can be used to aid the differentiation of adults with ADHD from adults with
ASD. Logistic regression revealed that the combination of CAARS-E and AQ10 successfully
classified 81% of participants but 16% of the ADHD sample were mis-classified as ‘ASD’
and 24% of the ASD sample as ‘ADHD’. The further addition of the composite measure from
the QbTest improved the classification accuracy to 90%; this was a statistically significant
improvement from the previous model comprising only the clinical rating scales and only two
individuals with ADHD (6%) and four with ASD (16%) were incorrectly assigned. Thus,
high scores on QbTotal improved correct assignment to the ADHD group, but also low scores
on QbTotal improved correct assignment to the ASD group, thereby aiding differential
diagnosis. The results provide some preliminary support for adding QbTest to standard
clinical rating scales to aid differentiation of ADHD from ASD in adults. In addition, we
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identified a Q-score of 1.12 associated with 84% sensitivity and 80% specificity to ADHD,
suggesting that this may be a useful cut-off predictive of ADHD when the sample comprises
individuals with ADHD and ASD diagnoses.
It should be noted that although statistically significant, the improvements in the
model with QbTest added are fairly modest and do not yield perfect results. Thus, although
these findings offer some promise for the use of a computerised cognitive test to augment
routine clinical diagnostic assessment, future research is needed to assess their reliability and
generalisability and to determine the stability of the putative cut-off score for ADHD. In
particular, further evidence is needed to help clinicians and healthcare service managers
decide whether adding QbTest to clinical assessment of ADHD is cost effective. A recent
audit reported that adding QbTest to ADHD assessment in a child and adolescent service
reduced time to diagnosis and resulted in cost savings (Hall et al., 2016). Although these
results offer some promise, further research is needed to determine how best to implement the
test to enhance diagnostic decision-making in a cost-effective way.
It is noteworthy that the univariate group ANOVA effects for Q-Impulsivity and
CAARS-Inattention failed to reach statistical significance after correction for multiple
comparisons. This suggests that these measures perform less well in differentiating between
ADHD and ASD than the other parameters. Furthermore, the mean Q-Activity score of 2.81
in the ADHD group indicates significant rates of activity in this adult group. This is
consistent with previous evidence (Lis et al., 2010) and suggests that when compared against
a large normative database (Ulberstad, 2012), hyperactivity is still present in adulthood in
ADHD. The relatively small sample size of the present study prevented inclusion of the
individual QbTest parameters and CAARS subscales in logistic regression. A further question
leading on from the present findings is therefore whether the individual parameters on
QbTest offer greater sensitivity and specificity compared with the composite measures used
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here. In particular, it would be useful to determine whether the Q-Activity parameter is
effective in differentiating the Combined and Inattentive ADHD sub-types. The present study
sample comprised mostly adults with the Combined sub-type and so this important question
could not be addressed here. Further research could also examine relationships between the
movement and attention parameters recorded by QbTest as there is evidence to suggest that
increases in activity may be intimately related to fluctuations in attention (Licht et al., 2009).
Certain limitations should be considered when interpreting the results. Firstly, the
research was limited to two specialist adult neurodevelopmental clinics in Nottinghamshire,
U.K. Although there is no reason to consider the participants or clinics were not
representative of other specialist ADHD or Asperger’s clinics, care should be taken when
generalising these findings to other sectors of the ADHD or ASD populations. In particular,
all those in the ASD group were diagnosed with Asperger’s Syndrome and were therefore
relatively high functioning and in the ADHD group, the majority were combined sub-type.
Secondly, in this study, we first sought to see if QbTest could aid the differentiation of two
neurodevelopmental diagnoses. In real-world clinical practice however, differential diagnoses
with adult ADHD are often complex with other co-occurring disorders being considered (e.g.
bipolar disorder or antisocial personality disorder). One previous study suggests QbTest may
fare less well when samples are more heterogeneous (Söderström et al., 2014). It will also be
important to determine whether the impressive sensitivity and specificity parameters reported
here are upheld in a sample that includes comorbid ADHD/ASD cases.
To conclude, the findings presented here suggest that adding a computerised cognitive
assessment to frequently used standard clinical rating scales of ADHD and ASD improves
correct diagnostic classification of these two neurodevelopmental disorders in adults. Further
work is needed to replicate these findings in larger, more diverse samples and to evaluate the
benefits and costs of including QbTest in clinical assessment. It will be important to further
15
establish an evidence base for this measure which has already been introduced into some
clinics.
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Table 1
Group Comparisons on QbTest Measures and Rating Scales
ADHD (n=32) ASD (n=25) Group comparison
Gender (% male) 63 76 χ2 = 1.18, ns
Age 31.64 (10.17) 33.22 (11.74) t= .55, ns
Socio-economic status
(IMD) (% Low, High,
Mid)
50, 32, 18 64, 24, 12 χ2 = 1.16, ns
Q-Activity 2.81 (1.09) 1.10 (1.45) F= 25.80, p < .001, ƞ2 = .32
Q-Impulsivity 1.45 (1.17) .58 (1.08) F= 8.30, p < .01, ƞ2 = .13
Q-Inattention 1.76 (1.24) .43 (1.07) F= 18.13, p < .001, ƞ2 = .25
CAARS-A Inattention 72.88 (9.78) 66.48 (12.38) F= 4.76, p<.05, ƞ2 = .08
CAARS-B Hyp/Rest 68.47 (6.41) 54.20 (11.79) F= 34.09, p < .001, ƞ2 = .38
CAARS-C Impulsivity 69.16 (9.99) 58.72 (8.68) F= 17.16, p < .001, ƞ2 = .24
CAARS-D Self Concept 63.94 (11.64) 62.96 (11.74) F= 1.00, ns
CAARS-E ADHD 75.69 (8.63) 64.32 (12.38) F= 16.67, p < .001, ƞ2 = .23
AQ10 5.44 (1.81) 7.36 (2.33) F= 12.32, p < .001, ƞ2 = .18
‘Q’ = q-score measure from QbTest
CAARS = Conners Adult ADHD Rating Scale
AQ10 = Autism Quotient 10-item version
IMD = Index of Multiple Deprivation: Low = decile ranks 1-3 representing high deprivation;
mid = decile ranks 4-7; High = decile ranks 8-10 representing low deprivation
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Table 2
Participant Assignment to the ADHD or ASD Group at Each Step of the Model
Predicted Group Membership
ADHD ASD Correct (%)
Step 1 (CAARS-E, AQ10)
ADHD (N =32) 27 5 84
ASD (N=25) 6 19 76
Step 2 (+ QbTotal)
ADHD (N =32) 30 2 94
ASD (N =25) 4 21 84
At each step the row for each group shows the numbers predicted by the model to belong to
the ADHD group (first column) and to the ASD group (second column). The final column
shows the accuracy of the step for each group.
CAARS-E = Conners Adult ADHD Rating Scale – subscale E (ADHD Index)
AQ10 = Autism Quotient 10-item version
QbTotal = index of activity on QbTest-plus, created by averaging the Q-scores for Q-
Activity, Q-Impulsivity and Q-Inattention
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Figure Captions
Figure 1 ROC Curve of CAARS-E and QbTotal
Sensitivity (y-axis) and specificity (x-axis) are shown for CAARS-E (blue line) and QbTotal
(green line) predicting ADHD group membership. The diagonal line (black) shows the
reference point of 0 sensitivity and specificity.
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